Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos

NCT02018159 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT02018159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02018159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
May 12, 2016
Enrollment
738 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility